Betahistin Dimesylate

Betahistin Dimesylate’s active substance binds to two histamine receptors and is used to treat Meniere’s disease and hydrops cochlea.

Formula: C10H20N2O6S2

Molecular weight: 328.41 g/mol

Molecular size: Small

Controlled Substance: No

Precursor: No

Indications: Other nervous system drugs

Axano Pharmaceuticals Ltd
contact us now